Saturday, Jun 20, 2026
Breaking
Search
Home
Business
Entertainment
News
Sports
Tech
World
Explore by Topics
Subscribe
Search
Business
Entertainment
News
Sports
Tech
World
Subscribe Newsletter
Daily Stories
Stock Alerts
Full Access
Subscribe to our newsletter to get our newest articles instantly!
I have read and agree to the terms & conditions
Immunitybio
Business
ImmunityBio Responds to FDA, Affirms Commitment to Advertising Compliance
April 6, 2026
Business
ImmunityBio Achieves 700% Revenue Growth, Expands Anktiva® Lung Cancer Approvals Globally
February 24, 2026
Business
ImmunityBio Stock Jumps 26% as FDA Details ANKTIVA Resubmission Plan
January 21, 2026
Business
ImmunityBio Engages FDA on ANKTIVA® Resubmission for Bladder Cancer Treatment
January 20, 2026
Business
ImmunityBio’s Revenue Soars 700%, Validating Citadel’s Prediction (NASDAQ:IBRX)
January 17, 2026
